W. Martin Kast, Ph.D., is a Professor of Molecular Microbiology & Immunology and Obstetrics & Gynecology, and Urology. He currently holds the Walter A. Richter Cancer Research Chair. He is the Co-Leader of the Tumor Microenvironment Program and Director of the Beckman Center for Immune Monitoring.
A native of the Netherlands, he earned his B.S. in Medical Biology in 1980, M.S., summa cum laude, in Medical Biology in 1983, and his doctorate, summa cum laude, in Medicine in 1987, from the University of Amsterdam in the Netherlands.
He is serving on multiple study sections and other advisory boards at NIH. His research involves the design of therapeutic cancer vaccines directed against human papilloma virus (HPV) and prostate cancer. Several of his therapeutic HPV vaccines have or are currently been tried out in clinical trials. He also studies the interaction of HPV with the human immune system to find out how HPV escapes immune detection and how to reverse that. He has published over 250 articles and is the inventor on 14 patents. His research is supported by an NIH grant. He is a recipient of the Antoni van Leeuwenhoek Research Award, the Royal Netherlands Academy of Arts and Sciences Career Award, the IRPC Eminent Scientist of the USA Award, and the USC/Mellon Award for Graduate Student Mentoring. He is an Associate Editor for Cancer Research, the Journal of Translational Medicine, International Reviews of Immunology and HPV Today. He currently serves on the advisory board of nine biotechnology companies.